nav-left cat-right
cat-right

Safety Dooms Novel Staph Vaccine

A phase II/III trial of V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, has been stopped for good following a risk-benefit analysis, according to Merck and Intercell AG. In April, the Data Monitoring Committee recommended suspending enrollment even though a pre-specified interim analysis showed that the trial did not meet futility criteria. No explanation was given. But a decision...

Cholesterol study shows niacin no good at cutting ...

(CBS/AP) Niacin seems to be no good, at least when it comes to helping prevent heart attacks. On Thursday the NIH stopped a study because people taking high doses of niacin saw no benefit. LDL cholesterol is the main cause of clogged arteries. Statin drugs, including brand names like Zocor and Lipitor as well as generic forms – are mainstays in lowering LDL. But many statin users have heart attacks, because LDL...

Researchers Find Cousin of Hepatitis C Virus in Do...

MONDAY, May 23 (HealthDay News) — Researchers report that they’ve discovered a virus similar to the human hepatitis C virus in dogs, a finding that might provide insight into how the germ evolved in people and perhaps lead to better treatments. About 200 million people around the world are thought to suffer from hepatitis C, including an estimated 3.2 million chronically infected people in the United States....

FDA Okays New HIV Drug

WASHINGTON — The FDA has approved rilpivirine (Edurant) for the treatment of HIV patients who have not yet begun therapy. The drug, a non-nucleoside reverse transcriptase inhibitor, is intended to be used as part of highly active anti-retroviral therapy (HAART) with at least two other medications, the agency said. Rilpivirine, also known as TMC278, is to be taken once a day with food and offers another medication...

Five New Alzheimer’s Genes Double Total as Doctors...

Five new genes have been definitively linked to Alzheimer’s disease, doubling the total confirmed by scientists and opening new areas for research into an illness that affects 35 million people globally. The genetic pathways were reported in two studies involving more than 50,000 people worldwide. Some of the connections found involve systems that control inflammation and cholesterol in the brain, while others affect how...

Iona Chemistry Professor Researches Cure For ALZ

New Rochelle, NY – Do curry spice, wine and apple skins hold the answer for finding a cure for Alzheimer’s disease, Parkinson’s disease and other neurological disorders? The results of a laboratory research project, recently published in the Journal of Neurochemistry, show that a chemical compound derived from these natural products may be used in neutralizing the toxic effects of chemicals associated with some...
Page 10 of 19« First...89101112...Last »